The 3'-untranslated Region of P21WAF1 MRNA is a Composite Cis-acting Sequence Bound by RNA-binding Proteins from Breast Cancer Cells, Including HuR and Poly(C)-binding Protein
Overview
Authors
Affiliations
Despite promoting growth in many cell types, epidermal growth factor (EGF) induces growth inhibition in a variety of cancer cells that overexpress its receptor. The cyclin-dependent kinase inhibitor p21(WAF1) is a central component of this pathway. We found in human MDA-468 breast cancer cells that EGF up-regulates p21(WAF1) mRNA and protein, through a combination of increased mRNA stability and transcription. The decay rate of a hybrid luciferase reporter full-length p21(WAF1) 3'-untranslated region (UTR) mRNA was significantly faster than that of a control mRNA. Transfections with a variety of p21(WAF1) 3'-UTR constructs identified multiple cis-acting elements capable of reducing basal reporter activity. Short wavelength ultraviolet light induced reporter activity in constructs containing the 5' region of the p21(WAF1) 3'-UTR, whereas EGF induced reporter activity in constructs containing sequences 3' of the UVC-responsive region. These cis-elements bound multiple proteins from MDA-468 cells, including HuR and poly(C)-binding protein 1 (CP1). Immunoprecipitation studies confirmed that HuR and CP1 associate with p21(WAF1) mRNA in MDA-468 cells. Over- and underexpression of HuR in MDA-468 cells did not affect EGF-induced p21(WAF1) protein expression or growth inhibition. However, binding of HuR to its target 3'-UTR cis-element was regulated by UVC but not by EGF, suggesting that these stimuli modulate the stability of p21(WAF1) mRNA via different mechanisms. We conclude that EGF-induced p21(WAF1) protein expression is mediated largely by stabilization of p21(WAF1) mRNA elicited via multiple 3'-UTR cis-elements. Although HuR binds at least one of these elements, it does not appear to be a major modulator of p21(WAF1) expression or growth inhibition in this system. CP1 is a novel p21(WAF1) mRNA-binding protein that may function cooperatively with other mRNA-binding proteins to regulate p21(WAF1) mRNA stability.
3'UTR Diversity: Expanding Repertoire of RNA Alterations in Human mRNAs.
Hong D, Jeong S Mol Cells. 2023; 46(1):48-56.
PMID: 36697237 PMC: 9880603. DOI: 10.14348/molcells.2023.0003.
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer.
Mehta M, Raguraman R, Ramesh R, Munshi A Adv Drug Deliv Rev. 2022; 191:114569.
PMID: 36252617 PMC: 10411638. DOI: 10.1016/j.addr.2022.114569.
RNA-Binding Proteins in the Regulation of Adipogenesis and Adipose Function.
Zhang P, Wu W, Ma C, Du C, Huang Y, Xu H Cells. 2022; 11(15).
PMID: 35954201 PMC: 9367552. DOI: 10.3390/cells11152357.
Zheng Y, Zhou Z, Wei R, Xiao C, Zhang H, Fan T J Transl Med. 2022; 20(1):343.
PMID: 35907982 PMC: 9338556. DOI: 10.1186/s12967-022-03552-y.
Hu Antigen R (HuR) Protein Structure, Function and Regulation in Hepatobiliary Tumors.
Lachiondo-Ortega S, Cardoso Delgado T, Banos-Jaime B, Velazquez-Cruz A, Diaz-Moreno I, Martinez-Chantar M Cancers (Basel). 2022; 14(11).
PMID: 35681645 PMC: 9179498. DOI: 10.3390/cancers14112666.